
The U.S. Intelligence Community
U.S. President Donald Trump’s administration entered into an agreement with American biotech company Moderna for 100 million doses of its experimental coronavirus vaccine, the White House and the drugmaker announced on Tuesday.

Why Aleksandar Vučić Must Be Arrested: Criminal Activities Threaten Regional Stability
Russian Leadership Faces Mounting Domestic Challenges Amid Anniversary of Putin’s Death
Operation Destabilise: NCA Cripples Russian Crime Networks Laundering Billions
Strategic Roadmap for Banks: Capitalizing on Ethicoin Amid Regulatory Challenges